Particulate adjuvant and innate immunity: Past achievements, present findings, and future prospects

International Reviews of Immunology

Volumn 32, Issue 2, 2013, Pages 209-220

  Kuroda, Etsushi ^a   Coban, Cevayir ^b   Ishii, Ken J ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Adjuvant; Alum; Innate immunity; Particulates; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ARACHIDONIC ACID; CRYOPYRIN; HEMOZOIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INFLAMMASOME; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; POLYSTYRENE; PROSTAGLANDIN E2; THYMIC STROMAL LYMPHOPOIETIN; URIC ACID;

ADJUVANT THERAPY; ALLERGIC ASTHMA; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; BASOPHIL; CELL ACTIVATION; CELL ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CRYSTAL STRUCTURE; CYTOKINE RELEASE; EOSINOPHIL; EXHAUST GAS; HOST CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; INNATE IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ASTHMA; HUMANS; IMMUNITY, INNATE; NANOSTRUCTURES; PARTICLE SIZE; PARTICULATE MATTER; PNEUMONIA; TH2 CELLS; VACCINES;

EID: 84876156655     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2013.773326     Document Type: Review

References (80)

1. Akira S. Innate immunity and adjuvants. Phil Trans R Soc B 2011;366:2748-2755.
2. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010;327:291-295.
3. Coquerelle C, Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev 2010;234:317-334.
4. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637-650.
5. Elinav E, Strowig T, Henao-Mejia J, Flavell Richard A. Regulation of the antimicrobial response by NLR proteins. Immunity 2011;34:665-679.
6. Loo Y-M, Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011;34:680-692.
7. Osorio F, Reis e Sousa C.Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 2011;34:651-664.
8. Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012;12:479-491.
9. Lambrecht BN, Kool M, Willart MAM, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009;21:23-29.
10. O'Hagan DT, Ott GS, De Gregorio E, Seubert A.The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine 2012;30:4341-4348.
11. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998;32:155-172. (Pubitemid 28267407)
12. Aimanianda V, Haensler J, Lacroix-Desmazes S, et al. Novel cellular and molecular mechanisms of induction of immune responses by aluminumadjuvants. Trends Pharmacol Sci 2009;30:287-295.
13. Marrack P,McKee AS,Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009;9:287-293.
14. Mancino D, Buono G, Cusano M,Minucci M. Adjuvant effects of a crystalline silica on IgE and IgG1 antibody production inmice and their prevention by themacrophage stabilizer poly-2-vinylpyridine N-oxide. Int Arch Allergy Appl Immunol 1983;71:279-281. (Pubitemid 13106414)
15. Sharp FA, RuaneD,Claass B, et al.Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 2009;106:870-875.
16. Nygaard UC, Aase A, LovikM.The allergy adjuvant effect of particles-genetic factors influence antibody and cytokine responses. BMC Immunol 2005;6:11.
17. Kuroda E, Ishii KJ, Uematsu S, et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 2011;34:514-526.
18. Inoue K, Koike E, Yanagisawa R, et al. Effects ofmulti-walled carbon nanotubes on amurine allergic airway inflammationmodel. Toxicol Appl Pharmacol 2009;237:306-316.
19. Nygaard UC, Hansen JS, SamuelsenM, et al. Single-walled andmulti-walled carbon nanotubes promote allergic immune responses inmice. Toxicol Sci 2009;109:113-123.
20. Ichinose T, Takano H, Miyabara Y, et al. Murine strain differences in allergic airway inflammation and immunoglobulin production by a combination of antigen and diesel exhaust particles. Toxicology 1997;122:183-192. (Pubitemid 27390690)
21. Lovik M, Hogseth AK, Gaarder PI, et al. Diesel exhaust particles and carbon black have adjuvant activity on the local lymph node response and systemic IgE production to ovalbumin. Toxicology 1997;121:165-178. (Pubitemid 27273790)
22. Kool M, Soullie T, vanNimwegen M, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J ExpMed 2008;205:869-882. (Pubitemid 351549884)
23. BehrensMD,WagnerWM, Krco CJ, et al.Theendogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity. Blood 2008;111:1472-1479. (Pubitemid 351213435)
24. WillartMAM,Lambrecht BN.The dangerwithin: endogenous danger signals, atopy and asthma. Clin Exp Allergy 2009;39:12-19.
25. Kool M, WillartMonique AM, van NimwegenM, et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011;34:527-540.
26. Kool M, Hammad H, Lambrecht B. Cellular networks controllingTh2polarization in allergy and immunity. F1000 Biol Rep 2012;4:6.
27. Coban C, Igari Y, Yagi M, et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involvesmalarial hemozoin and host TLR9. Cell HostMicrobe 2010;7:50-61.
28. Reese TA, Liang H-E, Tager AM, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007;447:92-96. (Pubitemid 46685837)
29. Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008;9:847-856.
30. Coban C, YagiM, Ohata K, et al.Themalarialmetabolite hemozoin and its potential use as a vaccine adjuvant. Allergol Int 2010;59:115-124.
31. Glenny AT, Pope CG,WaddingtonH,Wallace U. Immunological notes XVLL-XXIV. J Pathol Bacteriol 1926;29(1):31-40.
32. Harrison WT. Some observations on the use of alum precipitated diphtheria toxoid. Am J Public Health Nations Health 1935;25:298-300.
33. Holt LB. Developments in diphtheria prophylaxis. London: Heinemann; 1950.p. xvi; 181.
34. Hutchison S, Benson RA, Gibson VB, et al. Antigen depot is not required for alum adjuvanticity. FASEB J 2011;26:1272-1279.
35. Jordan MB. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 2004;304(5678):1808-1810. (Pubitemid 38787898)
36. Wang HB,Weller PF. Pivotal advance: eosinophilsmediate early alum adjuvant-elicited B cell priming and IgMproduction. J Leukoc Biol 2008;83:817-821. (Pubitemid 351959860)
37. McKee AS, Munks MW, MacLeod MKL, et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act As an adjuvant for specific immunity. J Immunol 2009;183:4403-4414.
38. Ohnmacht C, Schwartz C, Panzer M, et al. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010;33:364-374.
39. Shah HB, Devera TS, Rampuria P, et al. Type II NKT cells facilitate alum-sensing and humoral immunity. J Leukoc Biol 2012;92:883-893.
40. Brewer JM, Conacher M, Satoskar A, et al. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996;26:2062-2066. (Pubitemid 26297502)
41. Brewer JM, Conacher M, Hunter CA, et al. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. J Immunol 1999;163:6448-6454.
42. Al-Shami A, Spolski R, Kelly J, et al. A role for TSLP in the development of inflammation in an asthma model. J ExpMed 2005;202:829-839. (Pubitemid 41345971)
43. Chen ZG, Zhang TT, Li HT, et al. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS ONE 2013;8:e51268.
44. Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012;129:1048-1055e6.
45. SchnareM, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001;2:947-950. (Pubitemid 32976167)
46. Gavin AL,Hoebe K,Duong B, et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006;314:1936-1938. (Pubitemid 46026117)
47. Da Silva CA, Pochard P, Lee CG, Elias JA. Chitin particles are multifaceted immune adjuvants. Am J Respir Crit CareMed 2010;182:1482-1491.
48. Eisenbarth SC, Colegio OR, O'Connor W, et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008;453:1122-1126. (Pubitemid 351871731)
49. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-677. (Pubitemid 351928351)
50. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241. (Pubitemid 43372104)
51. Tiemi ShioM, EisenbarthSC, SavariaM, et al.Malarialhemozoin activates theNLRP3inflammasome through Lyn and Syk kinases. PLoS Pathol 2009;5:e1000559.
52. DostertC,Guarda G, Romero JF, et al.Malarialhemozoin is aNalp3inflammasomeactivating danger signal. PLoS ONE 2009;4:e6510.
53. Griffith JW, Sun T,McIntosh MT, Bucala R. Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 2009;183:5208-5220.
54. Li H, Willingham SB, Ting JP, Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect aremediated by NLRP3. J Immunol 2008;181:17-21.
55. Kool M, Petrilli V, De Smedt T, et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008;181:3755-3759.
56. Franchi L, Ńuñez G.The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur J Immunol 2008;38:2085-2089.
57. Pollock KG, ConacherM,Wei XQ, et al. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 2003;108:137-143. (Pubitemid 36232862)
58. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-521. (Pubitemid 37237047)
59. Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev 2010;233:203-217.
60. Ḿocsai A, Ruland J, Tybulewicz VLJ. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 2010;10:387-402.
61. Ng G, Sharma K, Ward SM, et al. Receptor-independent, direct membrane binding leads to cellsurface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008;29:807-818.
62. Flach TL, Ng G, Hari A, et al. Alum interaction with dendritic cellmembrane lipids is essential for its adjuvanticity. NatMed 2011;17:479-487.
63. Narumiya S. Prostanoids and inflammation: a new concept arising from receptor knockout mice. J MolMed (Berlin) 2009;87:1015-1022.
64. Fabricius D, Neubauer M, Mandel B, et al. Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J Immunol 2010;184:677-684.
65. Kuroda E, Yamashita U. Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 2003;170:757-764. (Pubitemid 36070526)
66. Koga K, Takaesu G, Yoshida R, et al. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 2009;30:372-383.
67. Boniface K, Bak-Jensen KS, Li Y, et al. Prostaglandin E2 regulatesTh17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J ExpMed 2009;206:535-548.
68. Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation andTh17 cell expansion. NatMed 2009;15:633-640.
69. Uematsu S, Matsumoto M, Takeda K, Akira S. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 2002;168:5811-5816. (Pubitemid 34556168)
70. Fedyk ER, Phipps RP. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA 1996;93:10978-10983. (Pubitemid 26333103)
71. Roper RL, Brown DM, Phipps RP. Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE. J Immunol 1995;154:162-170.
72. Delgado M, Leceta J, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J Immunol 1999;163:3629-3635. (Pubitemid 29450883)
73. DelgadoM, Gomariz RP, Ganea D. VIP/PACAP preferentially attractTh2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J 2004;18:1453-1455. (Pubitemid 39561612)
74. Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005;201:627-636.
75. Mariani V,Gilles S, Jakob T, et al. Immunomodulatory mediators frompollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction. J Immunol 2007;178:7623-7631. (Pubitemid 46898032)
76. Marichal T, Ohata K, Bedoret D, et al. DNA released from dying host cells mediates aluminum adjuvant activity. NatMed 2011;17:996-1002.
77. Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol 2007;28:33-38. (Pubitemid 44960157)
78. Robinson RT, Khader SA, Locksley RM, et al. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cellmigration. J Immunol 2008;181:5560-5567.
79. Nagel J, Svec D,Waters T, Fireman P. IgE synthesis inman. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids. J Immunol 1977;118:334-341. (Pubitemid 8028548)
80. Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol 2004;82:497-505. (Pubitemid 39421059)